
Treatment of active psoriatic arthritis with the PPAR ligand pioglitazone: an open-label pilot study

Immunological consequences of thalidomide treatment in Sjögren’s syndrome
Prevalence of the antiphospholipid syndrome in primary systemic vasculitis
Infectious origin of the antiphospholipid syndrome
HLA-C locus alleles may modulate the clinical expression of psoriatic arthritis
How aggressive should initial therapy for rheumatoid arthritis be?
SAPHO syndrome and pamidronate revisited
SAPHO syndrome and pamidronate revisited: reply
